Related Experiment Video
Updated: Jun 22, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Hepatitis B Elimination Globally: The Answer May Not Be the Same for Everyone
1Division of Infectious Diseases, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Global hepatitis B virus (HBV) elimination requires tailored strategies, as a one-size-fits-all approach is ineffective. Local prevalence, risk factors, and resources must guide country-specific HBV control efforts.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Significant progress has been made globally toward the elimination of hepatitis B virus (HBV).
- However, numerous countries are not on track to meet elimination goals.
- This highlights a critical gap in current global HBV control strategies.
Purpose of the Study:
- To analyze the limitations of uniform approaches to hepatitis B virus elimination.
- To emphasize the need for context-specific strategies in HBV control.
- To advocate for tailored public health interventions based on local data.
Main Methods:
- Review of global HBV prevalence data.
- Analysis of risk factor variations across different regions.
- Assessment of resource availability in diverse healthcare settings.
Main Results:
- A universal, one-size-fits-all strategy is insufficient for global hepatitis B virus elimination.
- Significant heterogeneity exists in HBV prevalence and risk factors worldwide.
- Resource limitations in many countries hinder the implementation of standardized control programs.
Conclusions:
- Effective hepatitis B virus elimination necessitates strategies adapted to local epidemiological contexts.
- Tailoring interventions to specific country prevalence, risk factors, and available resources is crucial.
- Country-specific approaches are essential to accelerate progress toward global HBV elimination goals.
More Related Videos
Related Concept Videos
Drug Elimination: Non-Renal Routes
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Drug Elimination: Overview
Excretion refers to removing a drug from the body, either in its unchanged form or as its metabolites. Nonvolatile and polar drugs are primarily excreted through the kidneys, with other pathways including bile, sweat, saliva, and milk. Volatile drugs such as anesthetic gases are excreted via the...
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Hepatic Drug Clearance: Role of Transporters

